Japan’s first domestically produced vaccine for the virus that causes COVID-19 has been cleared for regulatory approval.

Achieved Q1 2026 PEMGARDA® (pemivibart) net product revenue of $13.7 million, representing 22% growth versus Q1 2025 net product revenue of $11.3 ...

May 19 could prove critical in the hantavirus outbreak. Currently, no cases have been confirmed in people who were not on ...

TOKYO - The Japanese government on Thursday is set to announce that the current COVID-19 quasi-emergency measures in place ...

Scientists warn hantavirus may be as contagious as Covid as they identify 19 May as the critical date to discover whether the ...

With the recent contractions of hantavirus on a cruise ship, many are wondering how hantavirus differs from COVID-19.

If your social media feed looks anything like mine, hantavirus has completely overtaken it. Given that we’ve only recently moved on from the effects of the COVID-19 pandemic, it’s normal to see ...

As an infectious disease doctor, I am not panicked, but remain concerned. Our nation needs a plan for vaccines and antiviral ...

Wastewater surveillance in Bengaluru revealed hidden COVID surges, highlighting the need for robust public health monitoring ...

Doctors say the number of vaccinated mothers remains too low to show a measurable dip in infant hospitalisations.